Described as anti-obesity and anti-diabetic, FGF-21 and its receptor agonists improve insulin sensitivity (IS) and promote weight loss by stimulating brown fat thermogenesis and increasing release of adiponectin serum levels [27,28]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.